Te Riele Anneline S J M, Agullo-Pascual Esperanza, James Cynthia A, Leo-Macias Alejandra, Cerrone Marina, Zhang Mingliang, Lin Xianming, Lin Bin, Sobreira Nara L, Amat-Alarcon Nuria, Marsman Roos F, Murray Brittney, Tichnell Crystal, van der Heijden Jeroen F, Dooijes Dennis, van Veen Toon A B, Tandri Harikrishna, Fowler Steven J, Hauer Richard N W, Tomaselli Gordon, van den Berg Maarten P, Taylor Matthew R G, Brun Francesca, Sinagra Gianfranco, Wilde Arthur A M, Mestroni Luisa, Bezzina Connie R, Calkins Hugh, Peter van Tintelen J, Bu Lei, Delmar Mario, Judge Daniel P
Department of Medicine, Division of Cardiology, Johns Hopkins University School of Medicine, 1800 Orleans Street, Baltimore, MD, USA.
Division of Cardiology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht, the Netherlands.
Cardiovasc Res. 2017 Jan;113(1):102-111. doi: 10.1093/cvr/cvw234.
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) is often associated with desmosomal mutations. Recent studies suggest an interaction between the desmosome and sodium channel protein Na1.5. We aimed to determine the prevalence and biophysical properties of mutations in SCN5A (the gene encoding Na1.5) in ARVD/C.
We performed whole-exome sequencing in six ARVD/C patients (33% male, 38.2 ± 12.1 years) without a desmosomal mutation. We found a rare missense variant (p.Arg1898His; R1898H) in SCN5A in one patient. We generated induced pluripotent stem cell-derived cardiomyocytes (hIPSC-CMs) from the patient's peripheral blood mononuclear cells. The variant was then corrected (R1898R) using Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 technology, allowing us to study the impact of the R1898H substitution in the same cellular background. Whole-cell patch clamping revealed a 36% reduction in peak sodium current (P = 0.002); super-resolution fluorescence microscopy showed reduced abundance of Na1.5 (P = 0.005) and N-Cadherin (P = 0.026) clusters at the intercalated disc. Subsequently, we sequenced SCN5A in an additional 281 ARVD/C patients (60% male, 34.8 ± 13.7 years, 52% desmosomal mutation-carriers). Five (1.8%) subjects harboured a putatively pathogenic SCN5A variant (p.Tyr416Cys, p.Leu729del, p.Arg1623Ter, p.Ser1787Asn, and p.Val2016Met). SCN5A variants were associated with prolonged QRS duration (119 ± 15 vs. 94 ± 14 ms, P < 0.01) and all SCN5A variant carriers had major structural abnormalities on cardiac imaging.
Almost 2% of ARVD/C patients harbour rare SCN5A variants. For one of these variants, we demonstrated reduced sodium current, Na1.5 and N-Cadherin clusters at junctional sites. This suggests that Na1.5 is in a functional complex with adhesion molecules, and reveals potential non-canonical mechanisms by which Na1.5 dysfunction causes cardiomyopathy.
致心律失常性右室发育不良/心肌病(ARVD/C)常与桥粒基因突变相关。近期研究提示桥粒与钠通道蛋白Na1.5之间存在相互作用。我们旨在确定ARVD/C患者中SCN5A(编码Na1.5的基因)突变的患病率及生物物理特性。
我们对6例无桥粒基因突变的ARVD/C患者(男性占33%,年龄38.2±12.1岁)进行了全外显子组测序。我们在1例患者中发现SCN5A存在一种罕见的错义变异(p.Arg1898His;R1898H)。我们从该患者的外周血单个核细胞中生成了诱导多能干细胞衍生的心肌细胞(hIPSC-CMs)。然后使用成簇规律间隔短回文重复序列/Cas9技术将该变异校正为(R1898R),使我们能够在相同细胞背景下研究R1898H替代的影响。全细胞膜片钳记录显示钠电流峰值降低了36%(P = 0.002);超分辨率荧光显微镜显示闰盘处Na1.5(P = 0.005)和N-钙黏蛋白(P = 0.026)簇的丰度降低。随后,我们对另外281例ARVD/C患者(男性占60%;年龄34.8±13.7岁;52%为桥粒基因突变携带者)进行了SCN5A测序。5例(1.8%)受试者携带一种可能致病的SCN5A变异(p.Tyr416Cys、p.Leu729del、p.Arg1623Ter、p.Ser1787Asn和p.Val2016Met)。SCN5A变异与QRS时限延长相关(119±15 vs. 94±14 ms,P < 0.),所有SCN5A变异携带者在心脏成像上均有主要结构异常。
近2%的ARVD/C患者携带罕见的SCN5A变异。对于其中一种变异,我们证明了钠电流、闰盘处的Na1.5和N-钙黏蛋白簇减少。这表明Na1.5与黏附分子形成功能复合体,并揭示了Na1.5功能障碍导致心肌病的潜在非经典机制。